The ALS Game Board of Life
I’ve always looked forward to December; it’s a month filled with decorations, holiday gifts, and happy social gatherings. But this month eight years ago, ... Read more
Updates
-
-
$2.5M Awarded to Investigate Mechanisms Linking Neurodegenerative Diseases to Infections
A new research project that will investigate the seemingly unrelated mechanisms between neurodegenerative diseases and infections has been awarded $2.5 million from the Chan Zuckerberg ... Read more -
Graphene May be Used to Detect Biomarkers for ALS, Study Reports
Graphene, a material made up of a thin sheet of carbon, may be used in the future to detect and measure biomarkers able to ... Read more -
Biogen Acquires Full Rights to Develop, Market BIIB067 as Potential Treatment for ALS
Biogen has decided to exercise its option to acquire from Ionis Pharmaceuticals the exclusive rights to develop and commercialize BIIB067 as a potential treatment for amyotrophic ... Read more -
Affiliated Managers Group Gives $20M to Help Establish ALS Research Center
Global asset management company Affiliated Managers Group (AMG) has announced a $20 million matching gift to establish the Healey Center at Massachusetts General Hospital, the ... Read more
-
Strategies to Cope with ALS Need to Address Depression and Anxiety Together, Study Says
Depression and anxiety in amyotrophic lateral sclerosis (ALS) patients, even at low levels, are linked and ... -
Fruit Compound Called Resveratrol May Strengthen Abilities of Stems Cells of ALS Patients
A natural compound found in certain fruits and vegetables, called resveratrol, may help boost ... -
I’m Stepping Out of the Past to Fully Appreciate the Present
It’s hard to live in the present when the past feels as close as ... -
First Human Trial for ALS Treatment Candidate AT-1501 Begins Dosing
Anelixis Therapeutics has begun dosing patients in the first human trial of its amyotrophic lateral ... -
Gene Therapy Holds Promise to Treat ALS Caused by SOD1 Mutations, Preclinical Study Shows
An experimental gene therapy based on RNA interference (RNAi) shows potential to treat patients ... -
Cytokinetics Completes Enrollment for Phase 2 Trial Evaluating Reldesemtiv for ALS
Cytokinetics has completed patient enrollment in its Phase 2 trial to evaluate the safety ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Hypermetabolism in ALS Linked to Greater Functional Decline and Shorter Survival, Study Says
News
Patients with amyotrophic lateral sclerosis (ALS) show high prevalence of hypermetabolism, which leads to more rapid physical decline and earlier death, new study reports. The research, “Hypermetabolism in ALS is associated with greater functional decline and shorter survival,” appeared ... Read more